Distribution of aldehyde dehydrogenase (EC 1.2.1.3) in different subcellular locales suggests specific function for the isozymes. Purification of new isozymes from human liver and further characterization of the E1 and E2 isozymes, which are at present available in a homogeneous form, are the objectives of this proposal. The work with the homogeneous isozymes E1 and E2 will involve identification of their active and/or regulatory site(s) by chemical modification with group specific reagents, as well as with the affinity reagents, which will be developed on the basis of known substrate specificity of aldehyde dehydrogenase. Standard techniques of protein purification, including ion exchange and affinity chromatography, will be used. Characterization of the new isozymes will include: amino acid analysis, molecular weight of the isozymes and their subunits, peptide mapping, interaction with antibodies, substrate and coenzyme specificity and kinetic properties with acetaldehyde as substrate. Concurrently, aldehyde dehydrogenase content and isozyme distribution in crude extracts of different human tissues (post-mortem) from alcoholics and non-alcoholics will be investigated and isozymes from post-mortem liver of a diagnosed alcoholic will be purified for comparison with normal isozymes. The results will provide information about structural relationships, catalytic properties, human species-specific properties, and possibly, ways in which the isozymes from the normal individual differ from those of the alcoholic. Understanding of the role of aldehyde dehydrogenase in metabolic regulation also will be advanced. The chemical modification of the active site will, in addition to increasing knowledge, provide a means for designing specific inhibitors or activators of the individual isozymes, thus providing grounds for development of therapeutic agents useful for treatment of the alcoholic. In alcoholism aldehyde dehydrogenase functions in converting toxic acetaldehyde to a harmless product. Its role is essential for the health of the alcoholic, and knowledge of its properties is a basic requirements for rational interpretation of the research carried out under the Institutes Priorities of: """"""""Genetic Factors in Alcoholism"""""""", """"""""Fetal Alcohol Syndrome"""""""", and """"""""Alcoholism in Women"""""""".

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Research Project (R01)
Project #
2R01AA000186-15
Application #
3108707
Study Section
Alcohol Biomedical Research Review Committee (ALCB)
Project Start
1975-04-01
Project End
1989-12-31
Budget Start
1986-12-01
Budget End
1987-12-31
Support Year
15
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Rutgers University
Department
Type
Graduate Schools
DUNS #
038633251
City
New Brunswick
State
NJ
Country
United States
Zip Code
08901
Kikonyogo, A; Abriola, D P; Dryjanski, M et al. (1999) Mechanism of inhibition of aldehyde dehydrogenase by citral, a retinoid antagonist. Eur J Biochem 262:704-12
Chern, M K; Pietruszko, R (1999) Evidence for mitochondrial localization of betaine aldehyde dehydrogenase in rat liver: purification, characterization, and comparison with human cytoplasmic E3 isozyme. Biochem Cell Biol 77:179-87
Ambroziak, W; Izaguirre, G; Abriola, D et al. (1999) Metabolism of retinaldehyde by human liver and kidney. Adv Exp Med Biol 463:205-11
Ambroziak, W; Izaguirre, G; Pietruszko, R (1999) Metabolism of retinaldehyde and other aldehydes in soluble extracts of human liver and kidney. J Biol Chem 274:33366-73
Shah, P; Pietruszko, R (1999) Reaction-chemistry-directed sequence alignment of aldehyde dehydrogenases. Adv Exp Med Biol 463:9-14
Izaguirre, G; Kikonyogo, A; Pietruszko, R (1998) Methylglyoxal as substrate and inhibitor of human aldehyde dehydrogenase: comparison of kinetic properties among the three isozymes. Comp Biochem Physiol B Biochem Mol Biol 119:747-54
Dryjanski, M; Kosley, L L; Pietruszko, R (1998) N-tosyl-L-phenylalanine chloromethyl ketone, a serine protease inhibitor, identifies glutamate 398 at the coenzyme-binding site of human aldehyde dehydrogenase. Evidence for a second ""naked anion"" at the active site. Biochemistry 37:14151-6
Kikonyogo, A; Pietruszko, R (1997) Cimetidine and other H2-receptor antagonists as inhibitors of human E3 aldehyde dehydrogenase. Mol Pharmacol 52:267-71
Izaguirre, G; Kikonyogo, A; Pietruszko, R (1997) Tissue distribution of human aldehyde dehydrogenase E3 (ALDH9): comparison of enzyme activity with E3 protein and mRNA distribution. Comp Biochem Physiol B Biochem Mol Biol 118:59-64
Pietruszko, R; Kikonyogo, A; Chern, M K et al. (1997) Human aldehyde dehydrogenase E3. Further characterization. Adv Exp Med Biol 414:243-52

Showing the most recent 10 out of 15 publications